Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2
2019 ◽
Vol 31
(6)
◽
pp. 606-614
◽
2021 ◽
Vol 85
(3)
◽
pp. AB144
Keyword(s):
Keyword(s):
2017 ◽
Vol 7
(2)
◽
pp. 243-248
◽
2013 ◽
Vol 104
(5)
◽
pp. 409-417
Keyword(s):
2017 ◽
Vol 16
(6)
◽
pp. 588-594
◽
Keyword(s):